BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang L, Hu ZM, Jiang FX, Wang W. Stem cell therapy for insulin-dependent diabetes: Are we still on the road? World J Stem Cells 2022; 14(7): 503-512 [PMID: 36157527 DOI: 10.4252/wjsc.v14.i7.503]
URL: https://www.wjgnet.com/1948-0210/full/v14/i7/503.htm
Number Citing Articles
1
Ramin Raoufinia, Hamid Reza Rahimi, Ehsan Saburi, Meysam Moghbeli. Advances and challenges of the cell-based therapies among diabetic patientsJournal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05226-3
2
Alexandra Papadopoulou, Konstantinos I Papadopoulos. Successful lifestyle modifications may underlie umbilical cord-mesenchymal stromal cell effects in type 2 diabetes mellitusWorld Journal of Diabetes 2023; 14(3): 347-351 doi: 10.4239/wjd.v14.i3.347
3
Nizar I. Mourad, Pierre Gianello. PORCINE PANCREATIC ISLETS: FROM IN VITRO CHARACTERIZATION TO PRECLINICAL TRANSPLANTATIONEuropean Journal of Transplantation 2023; 1(3): 226 doi: 10.57603/EJT-275
4
Yunfei Luo, Peng Yu, Jianping Liu. The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challengesEndocrine 2024;  doi: 10.1007/s12020-024-03855-8
5
Maksym Skrypnyk. Current progress and limitations of research regarding the therapeutic use of adipose-derived stem cells: literature reviewJournal of Umm Al-Qura University for Applied Sciences 2024;  doi: 10.1007/s43994-024-00147-9